CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence.

Slides:



Advertisements
Similar presentations
January 12-13, 2006 Montpelier, VT Chronic Care Management for all Vermonters Kenneth E. Thorpe, Ph.D. Robert W. Woodruff Professor and Chair Department.
Advertisements

Mental Health is Integral to Overall Health. Health Issues Related to People with Serious Mental Illness People with SMI who receive services in the public.
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Terry R. Reid, MSW Jan Schnellman, MEd Quitline Promotion: Creating Demand for Services.
Bronx BREATHES: Resources and Technical Assistance for Improved Tobacco Treatment Barbara Hart, MPA David Lounsbury, PhD Claudia Lechuga, MS Hal Strelnick,
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
The Standards of Practice for a Tobacco Treatment Specialist (TTS) Gaylene Mooney, M.Ed., RRT-NPS, CTTS Program Director, Respiratory Therapy San Joaquin.
Arizona Adult Tobacco Survey Response to Health Professional Query Behavior Richard S. Porter, MS Bob Leischow, MPH Arizona Department of Health Services.
Clinical Network for Mental Health. With the exception of London, all the areas with a rate of more than 2,000 years of life lost per 100,000 patients.
The Role of Quitlines in Comprehensive Tobacco Cessation: Where are We Now; Where are We Going; and How do We Get There? Tamatha Thomas-Haase, MPA Manager,
1 The Impact of Smoking in Los Angeles County March 25, 2010 Jonathan Fielding, M.D., M.P.H., M.B.A Director of Public Health and Health Officer L.A. County.
Tobacco Cessation: Curb the Deadliest Epidemic Keith Bradley, MD Director, Research Associates Program at St. Vincent’s National Alliance of Research Associates.
The Ohio Partners for Smoke-Free Families 5A’s
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Infant Safe Sleep Resources North Carolina Carolinas Medical Center Charlotte, NC September 5, 2007 Christine O’Meara, MA, MPH.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Memorial Hermann Healthcare System Clinical Integration & Disease Management Dan Wolterman April 15, 2010.
Quittin’ Time: Helping Employees Become Tobacco-free June 2005.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
PROPRIETARY AND CONFIDENTIAL Internal Strategic Pharmacy Programs Placemat Background 1  Prescriptions are the most frequently used health care benefit,
1 Progress in the development, monitoring, and implementation of tobacco dependence treatment around the world 13 March, 2013 Boston, MA.
Integrated Treatment for Co-Occurring Disorders An Evidence-Based Practice.
Economics of Tobacco Use and Help-Seeking Behavior Bishwa Adhikari, Ph.D., Economist Office on Smoking and Health Centers for Disease Control and Prevention.
Quit For Life® Program Presented by Helen Farid 1.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
TOBACCO CONTROL INITIATIVE HCSD Disease Management Program Quarterly Meeting April 26, 2005 Sarah Moody Thomas, PhD Statewide Clinical Lead.
Umpqua Health Alliance Umpqua Community Health Center Extended Care Clinic Integrated clinic for patients with complex health and addiction issues.
1 David B. Abrams, Ph.D National Conference on Tobacco or Health Dec Boston The Centers for Behavioral & Preventive Medicine Brown Medical School,
The Center for Health Systems Transformation
TM Reimbursement for Tobacco Dependence Counseling: Employer, Managed Care, Medicaid ABBY C. ROSENTHAL, MPH Office on Smoking and Health ABBY C. ROSENTHAL,
2011 Diabetes Update Forum.  1) Be familiar with the evidence supporting the role of physical activity in the prevention of chronic disease  2) Develop.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Linking Together to.
Figure 1. Distribution of Individuals Covered by Private Health Insurance, by Type of Health Plan Comprehensive = health plan with no deductible or
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Tobacco Cessation Strategies and Resources: Epidemiology, Evidence and Availability May 29, 2013 The National Tobacco-Free College Campus Initiative: Building.
Click to edit Master subtitle style Aetna Behavioral Health Depression Initiatives June 2006.
VA National Center for Health Promotion and Disease Prevention Using USPSTF Recommendations in VHA Clinical Practice Linda Kinsinger, MD, MPH Chief Consultant.
TM Best Practices—2007 Centers for Disease Control and Prevention Deborah Houston McCall, MSPH, Program Consultant Program Services Branch Office on Smoking.
Helping Smokers on Medicaid Quit September 16, 2014 Paul G. Billings Senior VP, Advocacy & Education.
Community Development Block Grant Citizens Advisory Council October 2015.
National Strategy for Quality Improvement in Health Care June 15, 2011 Kana Enomoto Director Office of Policy, Planning, and Innovation.
P DESIGNING INCENTIVES: The Impact of P4P on Smoking Interventions Marc Manley, MD, MPH Vice President and Medical Director, Population Health.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers The Wisconsin Tobacco.
Population Health Janet Appel, RN, MSN Director of Informatics and Population Health.
FEHB, Federal Worksites, and Women’s Health Aligning for Success 1 Christine Hunter MD December 2, 2015.
Tobacco & SMI: Bending the Deadly Curve Gregory A. Miller, M.D. Mary Barber, M.D. Maxine Smalling, R.N. New York State Statewide Grand Rounds January 21,
TM Making the Case to Insurance Purchasers for Tobacco Use Treatment Coverage Maya Vijayaraghavan, Ph.D. Office on Smoking and Health National Conference.
Tobacco Use among our Members, 1999 and 2003 Marc Manley, M.D., M.P.H. 1 ; Steven S. Foldes, Ph.D. 1 ; Nina L. Alesci, M.P.H. 1 ; Michael Davern, Ph.D.
Strategies for integrated, population-based recruitment into telephone-based smoking cessation counseling Linda C. Lockard Senior Project Coordinator Center.
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
Partnering with the Michigan Tobacco Quitline Michigan Purchasers Health Alliance 17 September 2015.
Motivation to Quit Smoking Among Relatives of Lung Cancer Patients Ellen J. Hahn, DNS, RN Mary Kay Rayens, PhD Jennifer Hatcher, RN, PhD Mei Zhang, MPH,
11 Evidence-Based Prevention Interventions Involves assessing evidence of the effectiveness of two categories of preventive services: 1.Clinical preventive.
1 Lessons from the English smoking cessation services Robert West University College London Logroño, October
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Brief Intervention. Brief Intervention has a number of different definitions but usually encompasses: –assessment –provision of education, support and.
Overview of Cancer Health Policy Landscape
CDC’s 6|18 Initiative: Accelerating Evidence into Action American College of Preventive Medicine Utilizing the 6|18 Initiative to Address High Blood.
Neonatal Abstinence Syndrome (NAS) Program Overview
The Burden of Tobacco Use
Gary Mendell, Founder and CEO
Integrated Treatment for Co-Occurring Disorders
Information for Network Providers
New Opportunities in Medicare
Integrated Treatment for Co-Occurring Disorders
2008 Behavioral Health Symposium
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
Presentation transcript:

CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence Michael Burke, EdD Thomas Payne, PhD Christine Sheffer, PhD Ken Wassum, BA Michael Burke, EdD Thomas Payne, PhD Christine Sheffer, PhD Ken Wassum, BA ATTUD, 2008

ATTUD is an organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user attud.org Network of professionals with the clinical skills and background to provide evidence-based treatment for tobacco dependence Supportive infrastructure for all professionals interested in the treatment of tobacco dependence Network of professionals with the clinical skills and background to provide evidence-based treatment for tobacco dependence Supportive infrastructure for all professionals interested in the treatment of tobacco dependence

ATTUD is an organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user attud.org Network of professionals with the clinical skills and background to provide evidence-based treatment for tobacco dependence Supportive infrastructure for all professionals interested in the treatment of tobacco dependence Network of professionals with the clinical skills and background to provide evidence-based treatment for tobacco dependence Supportive infrastructure for all professionals interested in the treatment of tobacco dependence

ATTUD is an organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user attud.org Network of professionals with the clinical skills and background to provide evidence-based treatment for tobacco dependence Supportive infrastructure for all professionals interested in the treatment of tobacco dependence Network of professionals with the clinical skills and background to provide evidence-based treatment for tobacco dependence Supportive infrastructure for all professionals interested in the treatment of tobacco dependence

Tobacco Dependence Treatment Toolbox The critical importance of including treatment comprehensively into tobacco control, community health initiatives, and the entire healthcare delivery system Recognizing evidence-based treatments The different ways treatment can and should be effectively delivered How best to partner with the healthcare systems Resources The critical importance of including treatment comprehensively into tobacco control, community health initiatives, and the entire healthcare delivery system Recognizing evidence-based treatments The different ways treatment can and should be effectively delivered How best to partner with the healthcare systems Resources

435,000 Deaths 3 Fully Loaded 747s Crashing and Burning with No Survivors Every Day for One Year Jack Henningfield, PhD Smoking- attributable (18.2%) Out of All Deaths in the US

Number of average annual deaths Neoplasms Cardiovascular diseases Respiratory disease Total Perinatal conditions Burn deaths Total Lung cancer Ischemic heart disease Environmental Tobacco Smoke CDC, 2005 Smoking-Attributable Mortality,

We’ve come a long way, baby!

Treatment for Tobacco Dependence Gold Standard in Preventative Services Impact, effectiveness, cost-effectiveness Rapid improvements in functioning Money saved Quality of life Freedom from addiction Rapid improvements in functioning Money saved Quality of life Freedom from addiction

70% of adult smokers would like to quit... Current National Quit Rate 2-4% 40-50% of smokers will try to quit each year...

Current Smoking among Adults United States, 2000

Current Smoking among Adults United States, 2006

Trends in cigarette smoking: A flattening of the decline in prevalence National Health Interview Surveys (NCHS, CDC). 18.0% 23.9% Men Women

Those who can quit more easily do so in response to environmental and / or educational public health efforts Decrease in prevalence has slowed Smoking is now associated with  Fewer personal resources Lower Income Lower Education Less Access  Depression, Anxiety Disorders  Severe Psychopathology  Substance Dependence  Childhood Disorders Those who can quit more easily do so in response to environmental and / or educational public health efforts Decrease in prevalence has slowed Smoking is now associated with  Fewer personal resources Lower Income Lower Education Less Access  Depression, Anxiety Disorders  Severe Psychopathology  Substance Dependence  Childhood Disorders Hardening of the Target

Treatment is Serious Business Evidence-based treatments exist but are not widely disseminated Good results requires much more than Providing education Willpower Waiting for smoker to be “ready” Best results Combine multiple sessions of counseling and medication Collaboratively address relapse Promote recycling as needed Evidence-based treatments exist but are not widely disseminated Good results requires much more than Providing education Willpower Waiting for smoker to be “ready” Best results Combine multiple sessions of counseling and medication Collaboratively address relapse Promote recycling as needed

Treatment Intensity Intensive treatment can be delivered in multiple formats Group sessions Telephone counseling Individual face-to-face Components of intensive treatment include: Multiple contacts Behavioral counseling Decision support for medications, including extended use and combined medications

A Dose Response Relationship for Counseling: Efficacy Increases with Time Total amount of contact time Odds ratio (95% CI) Estimated abstinence rates (95% CI) No minutes minutes1.4 (1.1, 1.8)14.4 (11.3, 17.5) 4-30 minutes1.9 (1.5, 2.3)18.8 (15.6, 22.0) minutes3.0 (2.3, 3.8)26.5 (21.5, 31.4) minutes3.2 (2.3, 4.8)28.4 (21.3, 35.5) > 300 minutes2.8 (2.0, 3.9)25.5 (19.2, 31.7)

Efficacy Increases with Number of Sessions Total amount of sessions Odds ratio (95% CI) Estimated abstinence rates (95% CI) 0-1 sessions sessions1.4 (1.1, 1.7)16.4 (13.7, 19.0) 4-8 sessions1.9 (1.8, 2.2)20.9 ( ) > 8 sessions2.3 (2.1, 3.0)24.7 (21.0, 29.4)

Cost Effectiveness Cheaper is not always less expensive – sometimes it is just cheap! Intensive is defined by treatment components rather than treatment modality More intensive treatment is cost effective Oregon QL RCT: n-4,500 (Hollis et al, 2007) Cheaper is not always less expensive – sometimes it is just cheap! Intensive is defined by treatment components rather than treatment modality More intensive treatment is cost effective Oregon QL RCT: n-4,500 (Hollis et al, 2007)

Pharmacotherapy Give Patient a Menu of Covered Options Over –the-Counter Medications Prescription Medications

Trends in the Use of Treatment Medications Higher Doses Longer Clinical Treatment Combination Treatment Higher Doses Longer Clinical Treatment Combination Treatment

A Menu of Services is Needed Self-Help Group and Individual Treatment Group and Individual Treatment Telephone Treatment Brief Treatment from Health Care Providers Offer a range of intensities that maximize reach and effectiveness

Fax Back Tracking Referral And Follow-up Telephone- based Treatment Face-to-face Treatment Private Healthcare Providers Employee and Community Healthcare Partnering with the Healthcare System

Relapse after effective treatment for asthma, diabetes, or hypertension seen as evidence for treatment effectiveness Relapse after treatment for tobacco dependence is seen as evidence of treatment failure! We must change the way we look at this disease Relapse after effective treatment for asthma, diabetes, or hypertension seen as evidence for treatment effectiveness Relapse after treatment for tobacco dependence is seen as evidence of treatment failure! We must change the way we look at this disease Chronic Disease Treatment - Relapse

Treat tobacco dependence as a chronic illness Educate patients about true nature of tobacco dependence and refer to appropriate treatment Establish systems changes to support chronic disease management Consistent screening Medication management Treatment integrated into health-care system Ongoing monitoring and recycling into more intensive treatment as needed Appropriate coverage Eliminate out-of-pocket expenses Treat tobacco dependence as a chronic illness Educate patients about true nature of tobacco dependence and refer to appropriate treatment Establish systems changes to support chronic disease management Consistent screening Medication management Treatment integrated into health-care system Ongoing monitoring and recycling into more intensive treatment as needed Appropriate coverage Eliminate out-of-pocket expenses Conclusions

Summary Current treatments for tobacco dependence are needed Current treatments for tobacco dependence are effective A range of treatment options are needed All evidence-based treatments are under-utilized Broad-scale dissemination is feasible Effective training programs are available Widespread public acceptance will require strong, regular public health messages encouraging tobacco users to seek professional support when needed Current treatments for tobacco dependence are needed Current treatments for tobacco dependence are effective A range of treatment options are needed All evidence-based treatments are under-utilized Broad-scale dissemination is feasible Effective training programs are available Widespread public acceptance will require strong, regular public health messages encouraging tobacco users to seek professional support when needed

Action Steps Current treatments for tobacco dependence are needed  Review your treatment options  Do you offer a range of treatment options? Are you offering an intensive option? Phone? Face to face?  Are FDA approved meds covered?  Are you providing treatment regardless of readiness to quit? All evidence-based treatments are under-utilized  What % tobacco users are enrolling in services?  Are you offering low cost/no cost pharmacotherapy?  How is treatment adherence?  Are insurers fully covering treatment? Current treatments for tobacco dependence are needed  Review your treatment options  Do you offer a range of treatment options? Are you offering an intensive option? Phone? Face to face?  Are FDA approved meds covered?  Are you providing treatment regardless of readiness to quit? All evidence-based treatments are under-utilized  What % tobacco users are enrolling in services?  Are you offering low cost/no cost pharmacotherapy?  How is treatment adherence?  Are insurers fully covering treatment?

Action Steps (cont.) Broad-scale dissemination is feasible  How effective is the reach of your treatment offerings?  Is tx integrated into MH/SA settings? Effective training programs are available  Are your providers trained to ATTUD Core Competencies? (we can help! Widespread public acceptance will require strong, regular public health messages encouraging tobacco users to seek professional support when needed  Are you spending enough on paid promotion?  Have you analyzed what works in driving tobacco users to your services? Broad-scale dissemination is feasible  How effective is the reach of your treatment offerings?  Is tx integrated into MH/SA settings? Effective training programs are available  Are your providers trained to ATTUD Core Competencies? (we can help! Widespread public acceptance will require strong, regular public health messages encouraging tobacco users to seek professional support when needed  Are you spending enough on paid promotion?  Have you analyzed what works in driving tobacco users to your services?

ATTUD is an organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user attud.org ATTUD members can assist you in determining if Treatment is evidence-basedTreatment is evidence-based Providers are competentProviders are competent Training programs are effectiveTraining programs are effective Providers are certifiedProviders are certified